Basic Information
| RNALocate ID: | RLID:11001457 |
| RNA Symbol: | hsa-miR-199b-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-199b-5p |
| RNA ID: | miRBase:MIMAT0000263 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11001454 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001455 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001456 | Exosome | Brain tissue | 23382797 |
| RLID:11001458 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11001459 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001460 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000324 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001168 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-199b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-25054 |
| MNDR | hsa-miR-199b-5p | Oral squamous cell carcinoma | MNDR-E-MI-25055 |
| MNDR | hsa-miR-199b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-25056 |
| MNDR | hsa-miR-199b-5p | Medulloblastoma | MNDR-E-MI-25057 |
| MNDR | hsa-miR-199b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-25058 |
| MNDR | hsa-miR-199b-5p | Lymphoma | MNDR-E-MI-25059 |
| MNDR | hsa-miR-199b-5p | Lymphoma non-hodgkin | MNDR-E-MI-25060 |
| MNDR | hsa-miR-199b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-25061 |
| MNDR | hsa-miR-199b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-25062 |
| MNDR | hsa-miR-199b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-25063 |
| MNDR | hsa-miR-199b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-25064 |
| MNDR | hsa-miR-199b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-25065 |
| MNDR | hsa-miR-199b-5p | Niemann-pick disease type c | MNDR-E-MI-25066 |
| MNDR | hsa-miR-199b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-25067 |
| MNDR | hsa-miR-199b-5p | Dermatomyositis | MNDR-E-MI-25068 |
| MNDR | hsa-miR-199b-5p | Prostate cancer | MNDR-E-MI-25069 |
| MNDR | hsa-miR-199b-5p | Gastric cancer | MNDR-E-MI-25070 |
| MNDR | hsa-miR-199b-5p | Gastric lymphoma | MNDR-E-MI-25071 |
| MNDR | hsa-miR-199b-5p | Alzheimer disease | MNDR-E-MI-25072 |
| MNDR | hsa-miR-199b-5p | Intracranial aneurysm | MNDR-E-MI-25073 |
| MNDR | hsa-miR-199b-5p | Bladder cancer | MNDR-E-MI-25074 |
| MNDR | hsa-miR-199b-5p | Dysautonomia familial | MNDR-E-MI-25075 |
| MNDR | hsa-miR-199b-5p | Muscular dystrophy duchenne | MNDR-E-MI-25076 |
| MNDR | hsa-miR-199b-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-25077 |
| MNDR | hsa-miR-199b-5p | Head and neck cancer | MNDR-E-MI-25078 |
| MNDR | hsa-miR-199b-5p | Leukemia | MNDR-E-MI-25079 |
| MNDR | hsa-miR-199b-5p | Ataxia telangiectasia | MNDR-E-MI-25080 |
| MNDR | hsa-miR-199b-5p | Cardiovascular disease | MNDR-E-MI-25081 |
| MNDR | hsa-miR-199b-5p | Lung cancer | MNDR-E-MI-25082 |
| MNDR | hsa-miR-199b-5p | Parkinson disease | MNDR-E-MI-25083 |
| MNDR | hsa-miR-199b-5p | Niemann-pick disease | MNDR-E-MI-25084 |
| MNDR | hsa-miR-199b-5p | Breast cancer | MNDR-E-MI-25085 |
| MNDR | hsa-miR-199b-5p | Neuroendocrine neoplasia | MNDR-E-MI-25086 |
| MNDR | hsa-miR-199b-5p | Thyroid cancer | MNDR-E-MI-25087 |
| MNDR | hsa-miR-199b-5p | Pituitary neoplasms | MNDR-E-MI-25088 |
| MNDR | hsa-miR-199b-5p | Pancreatic cancer | MNDR-E-MI-25089 |
| MNDR | hsa-miR-199b-5p | Melanoma | MNDR-E-MI-25090 |
| MNDR | hsa-miR-199b-5p | Rectum adenocarcinoma | MNDR-E-MI-25091 |
| MNDR | hsa-miR-199b-5p | Nephroblastoma | MNDR-E-MI-25092 |
| MNDR | hsa-miR-199b-5p | Colon cancer | MNDR-E-MI-25093 |
| MNDR | hsa-miR-199b-5p | Colon adenocarcinoma | MNDR-E-MI-25094 |
| MNDR | hsa-miR-199b-5p | Ovarian cancer | MNDR-E-MI-25095 |
| MNDR | hsa-miR-199b-5p | Prostate adenocarcinoma | MNDR-E-MI-25096 |
| MNDR | hsa-miR-199b-5p | Carcinoma ductal breast | MNDR-E-MI-25097 |
| MNDR | hsa-miR-199b-5p | Glioblastoma | MNDR-E-MI-25098 |
| MNDR | hsa-miR-199b-5p | Astrocytoma | MNDR-E-MI-25099 |
| MNDR | hsa-miR-199b-5p | Glioma | MNDR-E-MI-25100 |
| MNDR | hsa-miR-199b-5p | Nemaline myopathy | MNDR-E-MI-25101 |
| MNDR | hsa-miR-199b-5p | Temporal lobe epilepsy | MNDR-E-MI-25102 |
| MNDR | hsa-miR-199b-5p | Osteosarcoma | MNDR-E-MI-25103 |
| MNDR | hsa-miR-199b-5p | Mesenchymal cancer | MNDR-E-MI-25104 |
| MNDR | hsa-miR-199b-5p | Breast carcinoma | MNDR-E-MI-25105 |
| MNDR | hsa-miR-199b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-25106 |
| MNDR | hsa-miR-199b-5p | Liver cancer | MNDR-E-MI-25107 |
| MNDR | hsa-miR-199b-5p | Choriocarcinoma | MNDR-E-MI-25108 |
| MNDR | hsa-miR-199b-5p | Uterus cancer | MNDR-E-MI-25109 |
| MNDR | hsa-miR-199b-5p | Gastric adenocarcinoma | MNDR-E-MI-25110 |
| MNDR | hsa-miR-199b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-25111 |
| MNDR | hsa-miR-199b-5p | Pituitary adenoma | MNDR-E-MI-25112 |
| MNDR | hsa-miR-199b-5p | Lung squamous cell carcinoma | MNDR-E-MI-25113 |
| MNDR | hsa-miR-199b-5p | Lung adenocarcinoma | MNDR-E-MI-25114 |
| MNDR | hsa-miR-199b-5p | Adrenocortical carcinoma | MNDR-E-MI-25115 |
| MNDR | hsa-miR-199b-5p | Thyroid carcinoma | MNDR-E-MI-25116 |
| MNDR | hsa-miR-199b-5p | Papillary thyroid carcinoma | MNDR-E-MI-25117 |
| MNDR | hsa-miR-199b-5p | Bladder urothelial carcinoma | MNDR-E-MI-25118 |
| MNDR | hsa-miR-199b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-25119 |
| MNDR | hsa-miR-199b-5p | Cervical cancer | MNDR-E-MI-25120 |
| MNDR | hsa-miR-199b-5p | Carcinoma renal cell | MNDR-E-MI-25121 |
| MNDR | hsa-miR-199b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-25122 |
| MNDR | hsa-miR-199b-5p | Clear cell renal cell carcinoma | MNDR-E-MI-25123 |
| MNDR | hsa-miR-199b-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-25124 |
| MNDR | hsa-miR-199b-5p | Cholangiocarcinoma | MNDR-E-MI-25125 |
| MNDR | hsa-miR-199b-5p | Esophageal cancer | MNDR-E-MI-25126 |
| MNDR | hsa-miR-199b-5p | Lung small cell carcinoma | MNDR-E-MI-25127 |
| MNDR | hsa-miR-199b-5p | Gastric carcinoma | MNDR-E-MI-25128 |
| MNDR | hsa-miR-199b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-25129 |
| MNDR | hsa-miR-199b-5p | Adenoma | MNDR-E-MI-25130 |
| MNDR | hsa-miR-199b-5p | Breast invasive carcinoma | MNDR-E-MI-25131 |
| MNDR | hsa-miR-199b-5p | Hepatocellular carcinoma | MNDR-E-MI-25132 |
| MNDR | hsa-miR-199b-5p | B-cell lymphoma | MNDR-E-MI-25133 |
| MNDR | hsa-miR-199b-5p | Rheumatoid arthritis | MNDR-E-MI-25134 |
| MNDR | hsa-miR-199b-5p | T-cell leukemia | MNDR-E-MI-25135 |
| MNDR | hsa-miR-199b-5p | Hodgkin lymphoma | MNDR-E-MI-25136 |
| MNDR | hsa-miR-199b-5p | Burkitt lymphoma | MNDR-E-MI-25137 |
| MNDR | hsa-miR-199b-5p | Tonsil cancer | MNDR-E-MI-25138 |
| MNDR | hsa-miR-199b-5p | Acute myelocytic leukemia | MNDR-E-MI-25139 |
| MNDR | hsa-miR-199b-5p | Colorectal cancer | MNDR-E-MI-25140 |
| MNDR | hsa-miR-199b-5p | Nasopharynx carcinoma | MNDR-E-MI-25141 |
| MNDR | hsa-miR-199b-5p | Diabetic nephropathies | MNDR-E-MI-25142 |
| MNDR | hsa-miR-199b-5p | Ependymoma | MNDR-E-MI-25143 |
| MNDR | hsa-miR-199b-5p | Cardiomegaly | MNDR-E-MI-25144 |
| MNDR | hsa-miR-199b-5p | Nasopharyngeal cancer | MNDR-E-MI-25145 |
| MNDR | hsa-miR-199b-5p | Prostatic neoplasms | MNDR-E-MI-25146 |
| MNDR | hsa-miR-199b-5p | Polymyositis | MNDR-E-MI-25147 |
| MNDR | hsa-miR-199b-5p | Pancreatitis chronic | MNDR-E-MI-25148 |
| MNDR | hsa-miR-199b-5p | Breast cancer her3+ negative | MNDR-E-MI-25149 |
| MNDR | hsa-miR-199b-5p | Tubulovillous adenoma | MNDR-E-MI-25150 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | APP | Homo sapiens | RR00091806 |
TOP